TLR8 agonist VTX-2337 enhances NKG2D-mediated cytotoxicity of NK cells
Hailing Lu, Yi Yang, Veronika Groh, Thomas Spies, Gregory Dietsch, Maura Matthews, Mary L Disis, Robert Hershberg
Journal for ImmunoTherapy of Cancer Nov 2013, 1 (Suppl 1) P44; DOI: 10.1186/2051-1426-1-S1-P44